Mood stabilizers can absolutely be taken in overdose, and the consequences range from mild confusion to organ failure and death. These drugs, most commonly lithium, valproate, carbamazepine, and lamotrigine, all have the potential to cause serious toxicity when taken in excess. What makes this class of medication particularly risky is how differently each drug behaves in overdose and how narrow the safety margin is for some of them, especially lithium.
Why Lithium Sits in a Category of Its Own
Among all mood stabilizers, lithium has the smallest gap between a dose that works and a dose that poisons. Blood levels need to stay within a tight range, generally between about 0.5 and 1.0 millimoles per liter for maintenance therapy. Once levels climb above 1.5, toxicity becomes likely. At levels above 2.5, the situation becomes dangerous, and levels above 4.0 in someone already taking lithium regularly can be life-threatening.
What makes lithium overdose especially unpredictable is that it comes in three distinct forms. A person who has never been on lithium and swallows a large amount in a single episode may not show severe symptoms right away, because the drug has not yet saturated the brain and kidneys. A small additional dose on top of regular lithium therapy, however, can push someone into severe toxicity because their tissues are already loaded with the drug. And chronic toxicity, where levels creep up gradually over days or weeks, often presents with vague symptoms like tremor, nausea, and confusion that get mistaken for other things before the situation becomes critical.1East Asian Archives of Psychiatry. Clinical Toxicology and Overdose of Psychiatric Medications
This distinction matters for treatment. In chronic toxicity, the clinical picture tends to be worse than the blood level alone would suggest, because the drug has had time to accumulate inside cells. In an acute single ingestion, the opposite can happen: blood levels look alarming while the person still feels relatively fine, because the lithium has not yet distributed into the brain.2Kidney and Dialysis. Indications for Dialysis in Lithium Toxicity: A Narrative Review Sustained-release lithium formulations add yet another wrinkle. In one case report, a patient who ingested 8,000 mg of a sustained-release lithium preparation had blood levels in the toxic range but remained completely asymptomatic more than 24 hours later, because the drug was still being slowly released from the tablet.3European Psychiatry. Overdose with sustained-release lithium preparations That kind of delayed absorption can give a false sense of security while a dangerous amount of lithium is still entering the bloodstream.
Common Medications That Can Accidentally Push Lithium to Toxic Levels
Not every lithium overdose is intentional. Because the kidneys handle lithium in much the same way they handle sodium, anything that changes how the kidneys process salt and water can tip lithium levels upward. Several widely prescribed medications are known to do exactly that.
Thiazide diuretics, commonly used for high blood pressure, have the strongest track record of raising lithium levels. Starting a thiazide can increase lithium concentrations by roughly 25 to 40 percent, which is easily enough to push someone from a safe level into a toxic one.4PubMed. Clinical relevance of drug interactions with lithium Nonsteroidal anti-inflammatory drugs like ibuprofen and naproxen can also raise lithium levels, though the degree varies from person to person and from one NSAID to another. ACE inhibitors and angiotensin receptor blockers, both standard blood pressure medications, similarly impair lithium clearance and are generally considered risky to combine with lithium without close monitoring.5PubMed Central. Lithium therapy and its interactions
Dehydration from illness, heavy exercise, or hot weather can have the same effect. When the body is low on fluids, the kidneys conserve sodium more aggressively, and lithium gets reabsorbed along with it. This means someone on a stable lithium dose for years can develop toxicity during a bout of gastroenteritis or after starting a new blood pressure pill. Anyone taking lithium should be aware that common over-the-counter painkillers and prescription medications for hypertension can interact in dangerous ways.6Archives of Clinical Psychiatry. Lithium interactions with non-steroidal anti-inflammatory drugs and diuretics – A review
Valproate Overdose and the Ammonia Problem
Valproate (also sold as valproic acid or divalproex) is the second most commonly seen mood stabilizer in overdose presentations. In one poison-center study from Egypt that tracked mood-stabilizer poisoning cases over nearly three years, carbamazepine accounted for the largest share of cases at about 58 percent, followed by valproic acid at roughly 30 percent, lithium at about 8 percent, and lamotrigine at around 5 percent.7PubMed Central. Assessment of the pattern, severity, and outcomes of acute mood stabilizer drug poisoning Those proportions reflect local prescribing patterns, but the general picture holds: valproate overdose is common in clinical toxicology.
Valproate is metabolized heavily by the liver, and one of the distinctive dangers of overdose is that it depletes the body’s stores of carnitine, a molecule the liver needs to process fatty acids properly. When carnitine runs low, ammonia builds up in the blood. High ammonia is toxic to the brain and can cause confusion, lethargy, and even coma, sometimes before other signs of poisoning are obvious.8PubMed Central. Hyperammonemia associated with valproic acid concentrations This ammonia buildup is not unique to overdose; it can happen at therapeutic doses too, especially with long-term high-dose use. But in overdose the effect is faster and more severe.
Because the mechanism is understood, there is a targeted treatment. Giving L-carnitine intravenously helps the liver resume normal processing and brings ammonia levels down. There is solid evidence supporting its use both after acute overdose and during chronic toxicity, though the ideal dosing strategy is still being worked out.9PubMed Central. L-carnitine for valproic acid-induced toxicity In severe cases, hemodialysis combined with L-carnitine has been used successfully.10Journal of Emergency Medicine Case Reports. Successful Treatment of Valproic Acid Intoxication with Hemodialysis and L-Carnitine
Carbamazepine and Delayed Absorption
Carbamazepine, used both as a mood stabilizer and an anticonvulsant, presents its own set of challenges in overdose. The drug slows gut motility, meaning it literally slows down its own absorption. A person who has taken a large amount may look stable initially, then deteriorate hours later as the drug finally enters the bloodstream. Symptoms of carbamazepine overdose center on the nervous system: drowsiness progressing to deep coma, respiratory depression, and seizures. Cardiac effects including abnormal heart rhythms are possible in severe cases.
A narrative review that pulled together data from 154 published reports found that the survival rate after carbamazepine poisoning treated with supportive care was about 82 percent. When hemoperfusion, a technique that filters the drug out of the blood using activated charcoal, was used in severe cases, it was effective about 58 percent of the time. For the most serious poisonings, hemodialysis is considered the first-choice extracorporeal treatment.11PubMed Central. Management of acute carbamazepine poisoning: A narrative review In one early case report, charcoal hemoperfusion cut a patient’s carbamazepine blood level nearly in half within two hours, a reduction that would have taken the body about 39 hours to achieve on its own.12Clinical Chemistry. Charcoal hemoperfusion for treatment of carbamazepine poisoning
Lamotrigine and the Heart
Lamotrigine is generally considered one of the safer mood stabilizers at therapeutic doses, which can create a misleading sense that it is benign in overdose. It is not. The most common toxic effects involve the central nervous system: seizures, involuntary movements, and reduced consciousness.13PubMed Central. Safety profile of lamotrigine in overdose But the more dangerous complication is cardiac. In massive overdose, lamotrigine can block sodium channels in the heart severely enough to cause life-threatening rhythm disturbances and cardiovascular collapse. Seizures may be the only warning sign before the heart starts to fail.14PubMed. Severe sodium channel blockade and cardiovascular collapse due to a massive lamotrigine overdose
Treatment for lamotrigine overdose is mostly supportive, but when sodium-channel blockade threatens the heart, sodium bicarbonate is the standard first-line therapy. In at least one reported case, sodium bicarbonate failed to restore normal cardiac conduction, and a lipid emulsion infusion was used instead, with rapid improvement. The idea is that the fat droplets in the emulsion soak up the lipid-soluble lamotrigine from the bloodstream.15PubMed. Lipid emulsion as rescue therapy in lamotrigine overdose However, expert consensus recommendations have actually suggested against using lipid emulsion as a first-line treatment for lamotrigine poisoning, noting that the evidence is not strong enough to recommend it routinely.16PubMed. Evidence-based recommendations on the use of intravenous lipid emulsion therapy in poisoning It remains a rescue option when standard treatments fail.
When the Damage Does Not Reverse
Most mood-stabilizer overdose survivors recover fully with appropriate treatment. But lithium carries a unique risk of permanent neurological injury known as the syndrome of irreversible lithium-effectuated neurotoxicity, or SILENT. The name is unfortunately accurate: the damage persists even after lithium is completely cleared from the body.
SILENT shows a strong preference for the cerebellum, the brain region responsible for coordination and balance. Persistent problems with walking, involuntary eye movements, slurred speech, and impaired fine motor control are the hallmark features. Brain imaging in affected patients often shows shrinkage and scarring in the cerebellum.17PubMed. Syndrome of Irreversible Lithium-Effectuated Neurotoxicity (SILENT): A Preventable Cerebellar Disorder Of the various lasting neurological problems reported, cerebellar dysfunction is the most common.18PubMed. The syndrome of irreversible lithium-effectuated neurotoxicity
One reason SILENT is particularly concerning is that it often begins during an episode of acute or acute-on-chronic lithium intoxication, and there is no way to predict at the outset whether a given patient will develop lasting damage. The condition is thought to be underreported and frequently misdiagnosed, in part because clinicians may attribute ongoing neurological symptoms to the psychiatric illness rather than recognizing them as a toxic injury to the brain.19PubMed Central. The Syndrome of Irreversible Lithium-Effectuated Neurotoxicity: A Scoping Review The key takeaway from clinicians who study SILENT is that it is preventable but permanent, meaning the emphasis has to be on catching lithium toxicity early rather than treating the neurological consequences after the fact.
How Mood-Stabilizer Overdoses Are Treated in the Emergency Department
There is no single antidote that works for all mood stabilizers, which is part of what makes these overdoses challenging. Treatment depends heavily on which drug was taken, how much, and how much time has passed.
For lithium, the drug is small enough to be filtered out of the blood by dialysis. Hemodialysis is considered when lithium levels are dangerously high, when the kidneys are not working well enough to clear the drug on their own, or when severe neurological symptoms are present despite levels that do not look catastrophic on paper. Specific thresholds have been established: hemodialysis is indicated for any patient with a lithium level above 6.0, for someone on chronic lithium therapy whose level exceeds 4.0, or for patients with levels between 2.5 and 4.0 who have severe symptoms or kidney failure.20PubMed Central. Hemodialysis Treatment for Patients with Lithium Poisoning One complication with lithium dialysis is “rebound”: the blood level drops during dialysis but then climbs again as lithium redistributes from tissue stores back into the blood, sometimes requiring repeated sessions.
For valproate, L-carnitine infusion addresses the ammonia-related toxicity directly. In severe cases, hemodialysis is added. For carbamazepine, the mainstay is supportive care with close monitoring, and extracorporeal removal is reserved for patients in deep coma or with failing organs. Lamotrigine overdose is managed supportively, with sodium bicarbonate for cardiac rhythm disturbances and benzodiazepines for seizures.
Across all these drugs, activated charcoal given within the first hour or two of ingestion can reduce how much drug the gut absorbs, but it only helps if the patient arrives early and is alert enough to swallow safely. For drugs with slow or erratic absorption, like carbamazepine and sustained-release lithium, multiple doses of activated charcoal are sometimes used.
Atypical Antipsychotics Used as Mood Stabilizers
Several atypical antipsychotics, including olanzapine, quetiapine, and aripiprazole, are now routinely prescribed as mood stabilizers, particularly for bipolar disorder. Their overdose profiles are different from the classic mood stabilizers. The most serious dangers involve the heart and the central nervous system. Overdose typically causes heavy sedation, rapid heart rate, low blood pressure, and prolongation of the heart’s electrical cycle, which can set the stage for dangerous arrhythmias.21PubMed. Toxicology and overdose of atypical antipsychotics
Olanzapine overdose in particular can cause deep sedation to the point of coma, along with constricted pupils, low blood pressure, and respiratory depression.22PubMed Central. Olanzapine Overdose in an Adult Male Presenting With Altered Sensorium and Pinpoint Pupil: A Case Report The constricted pupils are worth knowing about because they can mislead clinicians into suspecting opioid overdose rather than antipsychotic toxicity. Other clinical syndromes that can emerge after atypical antipsychotic overdose include neuroleptic malignant syndrome, a rare but potentially fatal reaction involving high fever and muscle rigidity, and antimuscarinic delirium, where the patient becomes agitated, flushed, and confused rather than sedated.21PubMed. Toxicology and overdose of atypical antipsychotics
Who Is Most at Risk
In the Egyptian poison-center study, the typical mood-stabilizer poisoning patient was young and female, and most cases were intentional rather than accidental.7PubMed Central. Assessment of the pattern, severity, and outcomes of acute mood stabilizer drug poisoning This aligns with broader patterns in medication self-poisoning, where people who already have access to psychiatric medications are at higher risk of using them in a suicide attempt. The severity of poisoning was significantly linked to the need for intensive care, the development of complications, and how long patients stayed in the hospital, particularly with carbamazepine and valproate.
Older adults and people with kidney problems face elevated risk from lithium in particular, because their kidneys clear the drug more slowly. Someone with well-functioning kidneys at age 30 who is stable on a given lithium dose may develop toxicity at that same dose after age-related kidney decline, a new blood pressure medication, or a period of dehydration. Regular blood-level monitoring is not optional with lithium; it is the primary safety mechanism. Guidelines recommend checking lithium levels every few months during stable treatment, and more frequently after any change in health status, medications, or fluid balance.23International Neuropsychiatric Disease Journal. Mood Stabilizers: Use, Drug Interactions, and Lithium Toxicity
Why Sustained-Release Formulations Complicate Everything
Several mood stabilizers come in extended-release or sustained-release versions designed to maintain steadier blood levels throughout the day. In normal use, this is a convenience. In overdose, it becomes a hazard. When someone swallows a large number of sustained-release tablets, the drug continues to trickle into the bloodstream for many hours after ingestion. Blood levels may keep rising long after the person arrives at the hospital, and standard interventions like gastric lavage or single-dose activated charcoal may miss the window entirely because most of the drug has not yet been released from the pill matrix.
The case mentioned earlier of a patient remaining symptom-free 25 hours after ingesting 8,000 mg of sustained-release lithium illustrates this clearly.3European Psychiatry. Overdose with sustained-release lithium preparations A clinician seeing stable vital signs and a reasonably alert patient might be tempted to discharge them, not realizing that the drug has barely begun to enter the system. For this reason, patients who overdose on sustained-release mood stabilizers generally need longer observation periods than those who take immediate-release formulations, and serial blood-level checks over 12 to 24 hours are standard practice. Whole-bowel irrigation, which flushes the entire gastrointestinal tract, is sometimes used to try to push sustained-release tablets through before they fully dissolve.
Carbamazepine presents a related problem even in its immediate-release form. Because the drug slows the movement of the gut, a large overdose can create a kind of internal reservoir, with undissolved tablets sitting in the stomach and intestines and gradually releasing drug over an extended period. Repeated doses of activated charcoal can help by binding carbamazepine as it continues to be released, but the delayed and unpredictable absorption still makes these cases harder to manage than overdoses of drugs that are absorbed quickly and predictably.